Awesome post Fattchoi thanks for sharing this link.
Hopefully people can be bothered to read it and fully understand the implications; namely there are so many shortcomings out there with existing standard of care drugs, both chemo and the big blockbuster monoclonal antibodies, and that Imugene's double platform IP has the potential to change things for the better. As has already been witnessed by initial data on HerVaxx with more to come.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.34M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 42.5¢ | 39.0¢ | $106.6K | 262.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 559 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 16517 | 2 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |